Literature DB >> 9365090

Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia.

V Agnello1, G Abel.   

Abstract

OBJECTIVE: To investigate the role of hepatitis C virus (HCV) in the pathogenesis of the cutaneous vasculitis in patients with type II cryoglobulinemia.
METHODS: Using in situ hybridization detection of HCV, we studied 6 test patients and various control subjects. Serum HCV was quantitated, cryoglobulins were analyzed by column chromatography at 37 degrees C, and low-density lipoprotein (LDL) receptors on keratinocytes were detected using LDL labeled with fluorescent dye.
RESULTS: In the cutaneous vasculitic lesions from test patients, but not control subjects, the HCV virion was found in association with IgM and IgG. HCV alone was detected in some vessel walls, and in skin and ductal epithelium and vascular endothelium in inflamed, but not normal, skin. Cryoglobulins showed HCV, monomeric IgM, and monomeric IgG, with little or no immune complexes. The extent of the lesions correlated with levels of viremia. Up-regulation of LDL receptors on keratinocytes was detected in inflamed, but not normal, skin.
CONCLUSION: HCV was present in the cutaneous vasculitic lesions, most likely in complexes with IgM and IgG formed in situ. These findings and the correlation of the severity of the rash with the level of viremia suggest that HCV plays a major role in the pathogenesis of cutaneous vasculitis in these patients and strengthens the rationale for antiviral drug therapy. The presence of HCV in keratinocytes and ductal epithelial and vascular endothelial cells may be the in vivo manifestation of endocytosis of HCV by the LDL receptors that has recently been demonstrated in vitro. The up-regulation of LDL receptors on keratinocytes in inflamed skin is consistent with this postulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9365090     DOI: 10.1002/art.1780401113

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  18 in total

1.  Mixed cryoglobulinaemia after hepatitis C virus: more and less ambiguity.

Authors:  V Agnello
Journal:  Ann Rheum Dis       Date:  1998-12       Impact factor: 19.103

Review 2.  Cryoglobulins in chronic hepatitis C virus infection.

Authors:  M Trendelenburg; J A Schifferli
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

Review 3.  Cryoglobulins and cryoglobulinemia. Diagnostic and therapeutic considerations.

Authors:  A Della Rossa; G Trevisani; S Bombardieri
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 4.  Extrahepatic immune related manifestations in chronic hepatitis C virus infection.

Authors:  Maria Tampaki; John Koskinas
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 5.  Cryoglobulins.

Authors:  C Ferri; A L Zignego; S A Pileri
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

6.  Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor.

Authors:  V Agnello; G Abel; M Elfahal; G B Knight; Q X Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

7.  Screening for Electrophysiological Abnormalities in Chronic Hepatitis C Infection: Peripheral Neuropathy and Optic Neuropathy.

Authors:  Aslı Köşkderelioğlu; Pınar Ortan; Alpay Ari; Muhteşem Gedizlioğlu
Journal:  Noro Psikiyatr Ars       Date:  2016-03-01       Impact factor: 1.339

8.  Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.

Authors:  Mohamed Hassan; Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader
Journal:  World J Exp Med       Date:  2012-04-20

Review 9.  The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review.

Authors:  Franco Dammacco; Vito Racanelli; Sabino Russi; Domenico Sansonno
Journal:  Clin Exp Med       Date:  2016-03-02       Impact factor: 3.984

10.  RNA interference and single particle tracking analysis of hepatitis C virus endocytosis.

Authors:  Kelly E Coller; Kristi L Berger; Nicholas S Heaton; Jacob D Cooper; Rosa Yoon; Glenn Randall
Journal:  PLoS Pathog       Date:  2009-12-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.